|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss for the 12 months | |||||
| Adjusted for: | |||||
| Equity settled share based payments | |||||
| Fair value movement in derivative financial instruments-warrants | |||||
| Depreciation and amortisation | |||||
| Net finance income | |||||
| Finance (costs) / income | |||||
| Share of losses of equity-accounted investee | |||||
| Onerous contract provision | |||||
| Impairment losses on assets | |||||
| Administration expenses: Loss/gain on sale of tangible assets | |||||
| Impairment on inventory | |||||
| Impairment on revenue | |||||
| Stock issued for Services | |||||
| Corporate Income Tax Expense | |||||
| Other income | |||||
| Discount on convertible Notes | |||||
| Profit / (loss) on deconsolidation due to insolvency | |||||
| Total adjustments | |||||
| Changes in working capital | |||||
| (Increase)/decrease in receivables | |||||
| (Increase)/decrease in inventories | |||||
| (Decrease)/increase in payables and accruals | |||||
| Interest paid | |||||
| Taxes received | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of property, plant and equipment | |||||
| Purchase of tangible assets | |||||
| Proceeds from sale of assets | |||||
| Development expenditure | |||||
| Purchase of intangible assets – other | |||||
| Receipt of government grants | |||||
| Payments to subsidiaries shareholders | |||||
| Investment in equity-accounted investees | |||||
| Cash derecognised on insolvency | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of shares | |||||
| Convertible note repayments | |||||
| Proceeds from PIPE issuance | |||||
| Proceeds from loans and borrowings | |||||
| Payment of lease liabilities | |||||
| Shareholder loan (repayment) / proceeds | |||||
| Net cash from financing activities | |||||
| Net increase/(decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents on consolidation with QIND | |||||
| Transfer from restricted cash | |||||
| Effects of movements in exchange rates on cash held | |||||
| Cash and cash equivalents | |||||
| Cash and cash equivalents at end of year | |||||
| Cash and cash equivalents at end of period | |||||
| Cash and cash equivalents on consolidation | |||||
| Add restricted cash | |||||
| Cash and cash equivalents at end of year including restricted cash | |||||
Loading...